Literature DB >> 2877743

Molecular structure of human lymphocyte receptor for immunoglobulin E.

H Kikutani, S Inui, R Sato, E L Barsumian, H Owaki, K Yamasaki, T Kaisho, N Uchibayashi, R R Hardy, T Hirano.   

Abstract

We have isolated and sequenced a cDNA clone encoding the human lymphocyte receptor for IgE (Fc epsilon R). The deduced protein sequence reveals that Fc epsilon R consists of 321 amino acids, without any signal sequence, and is oriented with its N-terminus on the cytoplasmic side and its C-terminus on the outside of the cell. This molecule shows striking sequence homology with chicken asialoglycoprotein receptor (hepatic lectin), suggesting a possible role for Fc epsilon R in endocytosis. Fc epsilon R mRNA is expressed in B cells, B cell lines, and macrophage cell lines. It is not expressed in T cells or T cell lines, with the exception of an HTLV-transformed T cell line. mRNAs expressed in a macrophage line and in the latter T cell line differ in size from mRNA expressed in B cells. Human BSF-1 (or IL-4) induces the expression of Fc epsilon R mRNA in B cells, but not in T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877743     DOI: 10.1016/0092-8674(86)90508-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  89 in total

1.  A microfilament formation inhibitor, cytochalasin strongly enhances the low-affinity Fc epsilon receptor II (CD23) expression on the human monocyte-like cell line, U937.

Authors:  N Ikewaki; H Tamauchi; A Yamada; M Aoki; R Yamamoto; A Sawada; H Inoko
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

2.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains.

Authors:  A Yokota; K Yukawa; A Yamamoto; K Sugiyama; M Suemura; Y Tashiro; T Kishimoto; H Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

Authors:  J Smith-Ravin; J Spencer; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  Regulation of IgE synthesis. Lymphocyte Fc epsilon receptor, IgE binding factor(s), and glycosylation-modulating factors.

Authors:  J Yodoi; T Kawabe; M Takami
Journal:  Clin Rev Allergy       Date:  1989

Review 6.  Low affinity IgE receptors (Fc epsilon RII).

Authors:  D H Conrad
Journal:  Clin Rev Allergy       Date:  1989

7.  Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1.

Authors:  C Carini; J Margolick; J Yodoi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

Authors:  M Billaud; P Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; T Tursz; G M Lenoir
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Influence of suramin on the expression of Fc receptors and other markers on human monocytes and U937 cells, and on their phagocytic properties.

Authors:  C Schiller; A Spittler; M Willheim; Z Szépfalusi; H Agis; M Köller; M Peterlik; G Boltz-Nitulescu
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid.

Authors:  H S Finstad; C A Drevon; M A Kulseth; A V Synstad; E Knudsen; S O Kolset
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.